IVIVR Assessing PK Parameters Used to Establish Bioequivalence

Conditions

• Healthy

Interventions

• DRUG: Zyloprim® 300 mg
• DRUG: Allopurinol 300 mg; undergranulated, high hardness condition
• DRUG: Allopurinol 300 mg; alternative condition 2
• DRUG: Allopurinol 300 mg; alternative condition 3

Sponsor

Ardea Biosciences, Inc.

Collaborators

• [object Object]